Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Rowland

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
BMJ Open|January 1, 2021
Observational cohort study with internal and external validation of a predictive tool for identification of children in need of hospital admission from the emergency department: the Paediatric Admission Guidance in the Emergency Department (PAGE) scoreAndrew Rowland, Sarah Cotterill, Calvin Heal, et al.
Molecules (Basel, Switzerland)|September 5, 2020
A Lanosteryl Triterpene (RA-3) Exhibits Antihyperuricemic and Nephroprotective Effects in RatsNomadlozi Blessings Hlophe, Andrew Rowland Opoku, Foluso Oluwagbemiga Osunsanmi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2015
In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine MetabolismPorntipa Korprasertthaworn, Thomas M Polasek, Michael J Sorich, et al.
European Journal of Clinical Pharmacology|May 25, 2019
Identification of the caffeine to trimethyluric acid ratio as a dietary biomarker to characterise variability in cytochrome P450 3A activityMadelé van Dyk, John O Miners, Jean-Claude Marshall, et al.
Clinical Breast Cancer|January 2, 2020
Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab EmtansineNatansh D Modi, Michael J Sorich, Andrew Rowland, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2016
Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumoursAndrew Rowland, Mafalda M Dias, Michael D Wiese, et al.
Cancer Chemotherapy and Pharmacology|December 2, 2019
Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanomaGanessan Kichenadasse, Jim Henry Hughes, John O Miners, et al.
British Journal of Cancer|September 11, 2015
Reply: Comment on 'Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal-antibody therapy for RAS wild-type metastatic colorectal cancer'Andrew Rowland, Mafalda M Dias, Michael D Wiese, et al.
Clinical Pharmacology and Therapeutics|March 26, 2018
Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Drug ExposureAndrew Rowland, Madelé van Dyk, Ashley M Hopkins, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2021
Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: An individual participant data meta-analysis of atezolizumab clinical trials: Smoking and immunotherapy efficacy in lung cancerAshley M Hopkins, Ahmad Y Abuhelwa, Ross A McKinnon, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
BMJ Open|January 1, 2021
Observational cohort study with internal and external validation of a predictive tool for identification of children in need of hospital admission from the emergency department: the Paediatric Admission Guidance in the Emergency Department (PAGE) scoreAndrew Rowland, Sarah Cotterill, Calvin Heal, et al.
Molecules (Basel, Switzerland)|September 5, 2020
A Lanosteryl Triterpene (RA-3) Exhibits Antihyperuricemic and Nephroprotective Effects in RatsNomadlozi Blessings Hlophe, Andrew Rowland Opoku, Foluso Oluwagbemiga Osunsanmi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 3, 2015
In Vitro Characterization of the Human Liver Microsomal Kinetics and Reaction Phenotyping of Olanzapine MetabolismPorntipa Korprasertthaworn, Thomas M Polasek, Michael J Sorich, et al.
European Journal of Clinical Pharmacology|May 25, 2019
Identification of the caffeine to trimethyluric acid ratio as a dietary biomarker to characterise variability in cytochrome P450 3A activityMadelé van Dyk, John O Miners, Jean-Claude Marshall, et al.
Clinical Breast Cancer|January 2, 2020
Predicting Thrombocytopenia in Patients With Breast Cancer Treated With Ado-trastuzumab EmtansineNatansh D Modi, Michael J Sorich, Andrew Rowland, et al.
European Journal of Cancer (Oxford, England : 1990)|January 27, 2016
Meta-analysis comparing the efficacy of anti-EGFR monoclonal antibody therapy between KRAS G13D and other KRAS mutant metastatic colorectal cancer tumoursAndrew Rowland, Mafalda M Dias, Michael D Wiese, et al.
Cancer Chemotherapy and Pharmacology|December 2, 2019
Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanomaGanessan Kichenadasse, Jim Henry Hughes, John O Miners, et al.
British Journal of Cancer|September 11, 2015
Reply: Comment on 'Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal-antibody therapy for RAS wild-type metastatic colorectal cancer'Andrew Rowland, Mafalda M Dias, Michael D Wiese, et al.
Clinical Pharmacology and Therapeutics|March 26, 2018
Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Drug ExposureAndrew Rowland, Madelé van Dyk, Ashley M Hopkins, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2021
Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: An individual participant data meta-analysis of atezolizumab clinical trials: Smoking and immunotherapy efficacy in lung cancerAshley M Hopkins, Ahmad Y Abuhelwa, Ross A McKinnon, et al.
Pageof 19